High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock

Critical Care Medicine

Volumn 28, Issue 9, 2000, Pages 3198-3202

  Martin, Claude ^a   Leone, Marc ^a   Viviand, Xavier ^a   Ayem, Marie Laure ^a   Guieu, Regis ^a  

^a HÔPITAL NORD   (France)

Author keywords

Adenosine; Circulatory failure; Hemorrhagic shock; Sepsis; Septic shock

Indexed keywords

ADENOSINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; HYPOVOLEMIC SHOCK; MALE; MEDIATOR RELEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SEPTIC SHOCK; SURVIVAL;

EID: 0033801235     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200009000-00014     Document Type: Article

References (43)

1. Sepsis: Definitions and diagnosis
2. Mortality risk prediction of sepsis
3. The pathogenesis of septic shock
4. Septic shock
5. Septic shock
6. Septic shock
7. Tumor necrosis factor is a mediator of phospholipase release during bacteremia in baboons
8. Prognostic values of serum cytokines in septic shock
9. The control of metabolism and the hormonal role of adenosine
10. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs
11. Cardiovascular effects of adenosine in man: Possible clinical implications
12. Effects of adenosine and adenine nucleotides on the atrioventricular node of isolated guinea pig hearts
13. Role of adenosine in local control of intestinal circulation in the dog
14. Adenosine and adenine nucleotides as possible mediators of cardiac and skeletal muscle blood flow regulation
15. Effect of blood transfusion hemorrhage on cardiac output and on the venous return curve
16. Hemorrhagic shock
17. Hemorrhagic shock: Update in pathophysiology and therapy
18. Selective microvascular endothelial cell dysfunction in the small intestine following resuscitated hemorrhagic shock
19. Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock
20. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
21. Use of HPLC to measure circulating adenosine levels in migrainous patients
22. Adenosin and neuropathic pain
23. Measurement of adenosine, inosine, and hypoxanthine in human plasma
24. Breakdown of adenine nucleotides, formation of oxygen free radicals, and early markers of cellular injury in endotoxin shock
25. Plasma levels of high-energy compounds compared with severity of illness in critically ill patients in the intensive care unit
26. A new method of sampling blood for measurement of plasma adenosine
27. Characterization of ectonucleotidases on vascular smooth-muscle cells
28. Regulation of adenosine metabolism by 5'-nucleotidases
29. Endothelial nucleotide catabolism and adenosine production
30. Adenosine metabolism in dog whole blood: Effects of dipyridamole
31. Turnover of adenosine in plasma of human and dog blood
32. Dipyridamole inhibition of adenosine metabolism in human blood
33. Receptors for purines and pyrimidines
34. Cardiovascular purinoreceptors
35. Evidence that adenosine contributes to maintenance of hepatosplanchnic blood flow during peritoneal sepsis in rats
36. Endotoxin induces bacterial translocation and increases xanthine oxidase activity
37. Mechanisms of endotoxin-induced intestinal injury in a hyperdynamic model of sepsis
38. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency
39. Adenosine deaminase deficiency in two patients with severely impaired cellular immunity
40. 2'deoxycoformycin and deoxyadenosine affect IL2 production and IL2 receptor expression of human T cells
41. Supply-to-demand ratio for oxygen determines formation of adenosine by the heart